Innovation

Houston Methodist Researcher Makes Bold Move by Releasing Nanotech ‘Recipe’


Dr-Tasciotti01
By Lisa Merkl | March 9, 2018

In a rare move, a Houston Methodist researcher is sharing his recipe for a new, more affordable way to make nanoparticles. This will empower any laboratory in the world to easily create similar nanoparticles and could lead to a whole new way of delivering biotherapeutic drugs and do it more quickly.

“We’re the only lab in the world doing this,” said Ennio Tasciotti, Ph.D., director of the Center for Biomimetic Medicine at the Houston Methodist Research Institute and corresponding author on a paper coming out March 7 in Advanced Materials. “There are several questions about how our system works, and I can’t answer all of them. By giving away the so-called ‘recipe’ to make biomimetic nanoparticles, a lot of other labs will be able to enter this field and may provide additional solutions and applications that are beyond the reach of only one laboratory. You could say it’s the democratization of nanotechnology.”

In the article, Tasciotti and his colleagues show how to standardize nanoparticle production to guarantee stability and reproducibility, while increasing yield. Eliminating the need for multi-million-dollar facilities, Tasciotti and his team demonstrate this using a readily available and relatively affordable piece of benchtop equipment to manufacture nanoparticles in a controlled, adjustable and low-cost manner.

“Nanoparticles are generally made through cryptic protocols, and it’s very often impossible to consistently or affordably reproduce them,” Tasciotti said. “You usually need special, custom-made equipment or procedures that are available to only a few laboratories. We provide step-by-step instructions so that now everybody can do it.”

For decades nanoparticles have been made out of bioinert, or inorganic, substances that don’t interact with the body. In more recent years, nanoparticles were made to be bioactive, meaning they could respond to the environment. Now, Tasciotti is pushing the field forward by creating biomimetic nanoparticles that resemble cell composition and work in synergy with the laws that govern the physiology of the body.

“The body is so smart in the ways it defends itself. The immune system will eventually recognize nanoparticles no matter how well you make them,” Tasciotti said. “In my lab, we make nanoparticles out of the cell membrane of the very same immune cells that patrol the blood stream. When we put these biomimetic, or bioinspired, nanoparticles back in the body, the immune cells do not recognize them as something different, as they’re made of their same building blocks, so there is no adverse response.”

Despite the complexity of this new class of particles, Tasciotti says it’s incredibly simple how they put it together, which is why he decided to publish this paper.

“While our lab will remain fully devoted to this line of research, if somebody else develops some solutions using our protocols that are useful in clinical care, it’s still a good outcome,” he said. “After all, the ultimate reason why we are in translational science is for the benefit of the patients.”

Other researchers collaborating with Tasciotti on this paper include his co-corresponding author Roberto Molinaro, Michael Evangelopoulos, Jessica R. Hoffman, Claudia Corbo, Francesca Taraballi, Jonathan O. Martinez and Kelly A. Hartman from Houston Methodist; Michael Sherman from University of Texas Medical Branch; and Donato Cosco, Giosue’ Costa, Isabella Romeo, Donatella Paolino, Stefano Alcaro from the University “Magna Græcia” of Catanzaro in Italy.

The work was supported by grants from the Cancer Prevention and Research Institute of Texas (RP170466), the NIH’s National Cancer Institute (R56CA213859), the Hearst Foundation and The Cullen Trust for Health Care.

Tasciotti is also the Director of the Center for Musculoskeletal Regeneration at the Houston Methodist Department of Orthopedics and Sport Medicine.




Social Posts

profile_image

Veterans Affairs

@DeptVetAffairs

How does a #Navy submariner from #Hollis #Queens #NYC become a #farmer in #NC?Check out the latest #BorneTheBattle to find out!iTunes: https://t.co/CCghj5FYUI Stitcher: https://t.co/rsLwa9Zmyr Blog: https://t.co/DeMB5MJ1cw https://t.co/sXnlH1Evh1

25 mins ago
profile_image

U.S. Department of Veterans Affairs

VeteransAffairs

“Veterans might be eligible for things they had no idea they were eligible for, no matter what age,” says Kim, an Army National Guard Veteran. She urges Veterans to take advantage of their VA benefits.#ExploreVA health care: http://bit.ly/2YiwKI6#WomensHistoryMonth

25 mins ago
profile_image

Veterans Affairs

@DeptVetAffairs

“Veterans might be eligible for things they had no idea they were eligible for, no matter what age,” says Kim, an Army National Guard Veteran. She urges Veterans to take advantage of their VA benefits.#ExploreVA health care: https://t.co/0NWKCkAgpl#WomensHistoryMonth

2 hours ago
profile_image

Texas Children's

@TexasChildrens

Sintoniza y escucha Liberman Media Radiotón en EL NORTE 107.9FM, LA RAZA 103.3FM o 98.5FM y La Ranchera 850AM o 101.7FM el 28 y 29 de marzo. Obtén más información: https://t.co/oc0IpWZQ7e https://t.co/Iylq9eQw6V

9 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Veterans talking Veterans back from the brink: A new approach to policing and lives in crisis https://t.co/uVpsxq1Pgs via @washingtonpost

10 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

How we’re helping #AYAcancer patients and survivors navigate life with #cancer: https://t.co/4xILlEE9VU @mroth_MD @jalivingston_md #endcancer

11 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

In cohort of #melanoma and #kidneycancer patients, study led by @JenWargoMD found B cells may be effective in predicting which #cancer patients will respond to #immunotherapy: https://t.co/5yQlDjKwCX #CancerMoonshot #AACR19 #endcancer

11 hours ago
profile_image

Memorial Hermann

@memorialhermann

After delaying her colonoscopy, 66-year-old Brenda’s screening revealed shocking news—she had cancer. Read her story: https://t.co/EVuApzmgPK

12 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

@MrsDeniseannco3 @MelanomaReAlli @washingtonpost @NobelPrize We'll be thinking of your husband.

12 hours ago
profile_image

MD Anderson Cancer Center

MDAnderson

“We’re working on ways to improve the function of the blood vessels so we can get chemotherapy to the places that need it most – the tumors,” says Dr. Keri Schadler, whose research is exploring how exercise can help get chemotherapy into solid tumors more efficiently, leading our patients toward better outcomes. #endcancer

12 hours ago
profile_image

Rice University

@RiceUniversity

RT @BakerInstitute: Starting Now: Anita Hill takes the stage to talk about how to stop sexual harassment in the workplace. #MeTooWatch th…

13 hours ago
profile_image

Rice University

@RiceUniversity

RT @RiceUNews: "I suspect that many of you have the idea that things are so entrenched that we can’t make change," Anita Hill tells the cro…

13 hours ago
profile_image

Memorial Hermann

MemorialHermann

After delaying her colonoscopy, 66-year-old Brenda’s screening revealed shocking news—she had cancer. Read her story: http://spr.ly/6187EZ2YN

13 hours ago
profile_image

BCMHouston

@bcmhouston

Our investigators conduct hundreds of studies, ranging from small, short-term studies to large trials with thousands of patients across many institutions. See our current clinical trials: https://t.co/3ulBSYdEhZ #clinicaltrials #research https://t.co/Sf6yBq7Dmm

13 hours ago
profile_image

Baylor College of Medicine

BaylorCollegeOfMedicine

Have you voted in STAT Madness yet? Our research on a common antibiotic that has been shown to damage the heart is looking to make it into the Final 4. #STATMadness

13 hours ago